Literature DB >> 24390269

Assessing disease severity and activity in patients with familial Mediterranean fever.

S Kapoor1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24390269     DOI： 10.1007/s10753-013-9803-z

Source DB:  PubMed          Journal:  Inflammation        ISSN： 0360-3997            Impact factor:   4.092


× No keyword cloud information.
  15 in total

1.  Quality of life in adult patients with Familial Mediterranean fever living in Germany or Turkey compared to healthy subjects: a study evaluating the effect of disease severity and country of residence.

Authors:  Arnd Giese; Mustafa Kurucay; Levent Kilic; Ahmet Örnek; Süleyman Nahit Şendur; Elke Lainka; Bernhard Ferdinand Henning
Journal:  Rheumatol Int       Date:  2012-12-29       Impact factor: 2.631

2.  [Serum levels of myeloid-related protein MRP 8/14 (calprotectin) in Armenian patients with familial mediterranean fever].

Authors:  Z T Dzhndoian
Journal:  Ter Arkh       Date:  2012       Impact factor: 0.467

3.  As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio.

Authors:  Ahmet Ahsen; Memnune Sena Ulu; Seref Yuksel; Kasım Demir; Mukremin Uysal; Mujgan Erdogan; Gursel Acarturk
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 4.  AA amyloidosis: basic knowledge, unmet needs and future treatments.

Authors:  Laura Obici; Giampaolo Merlini
Journal:  Swiss Med Wkly       Date:  2012-05-31       Impact factor: 2.193

5.  The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with familial Mediterranean fever.

Authors:  Ismail Sari; Arif Yuksel; Didem Kozaci; Sema Selcuk; Goksel Gokce; Yasar Yildiz; Hakan Demirel; Gulten Sop; Ahmet Alacacioglu; Necati Gunay; Nurullah Akkoc
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

6.  Cystatin C in serum as an early marker of renal involvement in Familial Mediterranean Fever patients.

Authors:  K Deveci; A K Gokakin; S Senel; H Deveci; A U Uslu; E Sancakdar
Journal:  Eur Rev Med Pharmacol Sci       Date:  2013-01       Impact factor: 3.507

7.  Can serum fetuin-A be regarded as an inflammatory marker among patients with familial Mediterranean fever?

Authors:  Kemal Oncu; Yusuf Yazgan; Alpaslan Tanoglu; Mustafa Kaplan; Fatih Ermis; Osman Metin Ipcioglu; Muammer Kara; Irfan Kucuk; Halil Onur Ozari
Journal:  Dig Dis Sci       Date:  2013-08-08       Impact factor: 3.199

8.  Leukopenia in familial Mediterranean fever: case series and literature review with special emphasis on pathogenesis.

Authors:  Deniz Aslan
Journal:  Pediatr Hematol Oncol       Date:  2013-04-05       Impact factor: 1.969

9.  The role of S100A12 as a systemic marker of inflammation.

Authors:  B Meijer; R B Gearry; A S Day
Journal:  Int J Inflam       Date:  2012-07-03

10.  Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases.

Authors:  Kari Hemminki; Xinjun Li; Asta Försti; Jan Sundquist; Kristina Sundquist
Journal:  BMC Med Genet       Date:  2013-09-03       Impact factor: 2.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.